Evidence map›Paper›PMID 26776227›Full record

ArticleSchizophrenia research2016

NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure.

Tobias B Halene, Alexey Kozlenkov, Yan Jiang, Amanda C Mitchell, Behnam Javidfar, Aslihan Dincer, Royce Park, Jennifer Wiseman, Paula L Croxson, Eustathia Lela Giannaris and 5 more

Abstract read
In one paragraph

Article in Schizophrenia research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Imaging of the superficial white matter in health and disease.Imaging neuroscience (Cambridge, Mass.) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. The P2XFrontiers in molecular neuroscience · 2021
    Article
  10. Review
  11. Clozapine As Transformative Treatment In Bipolar Patients.Neuropsychiatric disease and treatment · 2019
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Tobias B HaleneDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: tobias.halene@mountsinai.org.
Alexey KozlenkovDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Yan JiangDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Amanda C MitchellDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Behnam JavidfarDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Aslihan DincerDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Royce ParkDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Jennifer WisemanDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Paula L CroxsonFishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Eustathia Lela GiannarisDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA, USA.
Patrick R HofFishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Panos RoussosDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Science and Institute for Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Stella DrachevaDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Scott E HembyDepartment of Physiology and Pharmacology, Wake Forest University, Winston-Salem, NC, USA.
Schahram AkbarianDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn School of Medicine at Mount Sinai · USUniversity of Massachusetts Chan Medical School · USWake Forest University · US

Funding

Higher Order Chromatin and Genetic Risk for Alzheimer's DiseaseR01AG050986 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ROUSSOS, PANAGIOTIS · 2015 to 2025
$11.2M
Epigenome Mapping in Cortical InterneuronsR01MH093332 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AKBARIAN, SCHAHRAM · 2011 to 2015
$1.7M
Entorhinal Transcriptome in SchizophreniaR01MH074313 · NIMH · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HEMBY, SCOTT EDWARDS · 2005 to 2009
$1.4M
GABA Epigenomes in AutismR21MH103877 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DRACHEVA, STELLA · 2014 to 2015
$447k
Genetic and Molecular Determinants of SuicideI01BX001829 · VA · JAMES J PETERS VA MEDICAL CENTER · PI DRACHEVA, STELLA · 2014 to 2016
–
Dissecting Cis Regulation of Gene Expression in SchizophreniaI01BX002395 · VA · JAMES J PETERS VA MEDICAL CENTER · PI ROUSSOS, PANAGIOTIS · 2014 to 2022
–
BLRD VA I01 BX001829BLRD VA I01 BX002395NIA NIH HHS R01 AG050986NIMH NIH HHS MH074313NIMH NIH HHS R01 MH074313NIMH NIH HHS R01 MH093332NIMH NIH HHS R21 MH103877
6 · The paper itself

Abstract

Increased neuronal densities in subcortical white matter have been reported for some cases with schizophrenia. The underlying cellular and molecular mechanisms remain unresolved. We exposed 26 young adult macaque monkeys for 6 months to either clozapine, haloperidol or placebo and measured by structural MRI frontal gray and white matter volumes before and after treatment, followed by observer-independent, flow-cytometry-based quantification of neuronal and non-neuronal nuclei and molecular fingerprinting of cell-type specific transcripts. After clozapine exposure, the proportion of nuclei expressing the neuronal marker NeuN increased by approximately 50% in subcortical white matter, in conjunction with a more subtle and non-significant increase in overlying gray matter. Numbers and proportions of nuclei expressing the oligodendrocyte lineage marker, OLIG2, and cell-type specific RNA expression patterns, were maintained after antipsychotic drug exposure. Frontal lobe gray and white matter volumes remained indistinguishable between antipsychotic-drug-exposed and control groups. Chronic clozapine exposure increases the proportion of NeuN+ nuclei in frontal subcortical white matter, without alterations in frontal lobe volumes or cell type-specific gene expression. Further exploration of neurochemical plasticity in non-human primate brain exposed to antipsychotic drugs is warranted.

Indexed as

Administration, OralAnimalsAntipsychotic AgentsBrainCell CountClozapineFemaleFlow CytometryGray MatterHaloperidolImmunohistochemistryMacacaMagnetic Resonance ImagingMaleNerve Tissue ProteinsNeuronal PlasticityAntipsychotic AgentsClozapineHaloperidolNerve Tissue ProteinsAntipsychoticClozapineFlow cytometryMonkeySchizophreniaWhite matter

Identifiers

PMID26776227
PMCPMC4740223
OpenAlexW2225132318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.